李云++++++罗乐++++++何倩++++++张琳++++++韩亚骞++++++刘峰++++++刘林++++++马宏志


[摘要]目的 观察多西他赛联合顺铂治疗晚期头颈部肿瘤的临床效果及毒副作用。方法 将2013年12月~2015年12月我院收治的58例晚期头颈部肿瘤患者,依据不同的治疗方案分为观察组30例和对照组28例,观察组患者给予多西他赛联合顺铂治疗,对照组给予氟尿嘧啶联合顺铂治疗,治疗结束后1个月评价患者的临床效果及毒副作用。结果 观察组有效率为66.7%,高于对照组的39.3%,差异有统计学意义(P<0.05)。毒副作用主要表现为胃肠道反应、骨髓抑制,观察组胃肠道不良反应与骨髓抑制发生率明显低于对照组,差异有统计学意义(P<0.05)。结论 晚期头颈部肿瘤患者采用多西他赛联合顺铂化疗方案具有较为满意的临床疗效,且毒副作用轻微,值得临床推广应用。
[关键词]多西他赛;顺铂;晚期头颈部肿瘤
[中图分类号] R739.91 [文献标识码] A [文章编号] 1674-4721(2016)10(c)-0062-03
[Abstract]Objective To observe clinical efficacy and toxicity of Docetaxel plus Cisplatin in treatment of patients with advanced head and neck cancer.Methods 58 patients with advanced head and neck cancer in our hospital from December 2013 to December 2015 were divided into observation group (n=30) and control group (n=28) according to different treatment regimen.Patients in the observation group were given with Docetaxel plus Cisplatin treatment regimen,patients in the control group received Fluorouracil plus Cisplatin treatment regimen.The clinical efficacy and toxicity after a month were evaluated and compared between two groups after treatment for one month.Results The response rate in the observation group was 66.7%,higher than 39.3% in the control group,and the difference was statistically significant (P<0.05).The toxicities of two groups were mainly gastrointestinal reactions,bone marrow suppression,and incidence of gastrointestinal reactions and bone marrow suppression in observation group was obviously lower than that in the control group,and the difference was statistically significant (P<0.05).Conclusion Patients with advanced head and neck cancer treated by Docetaxel plus Cisplatin chemotherapy can get a more satisfactory clinical efficacy and mild toxicity and it should be introduced in clinical practice.
[Key words]Docetaxel;Cisplatin;Advanced head and neck cancer
头颈部肿瘤占全身恶性肿瘤的5%~8%,其治疗一直是个临床难题。早期发病患者可采用根治手术治疗,但约2/3的患者诊断时处于中晚期,导致错失最佳手术时机,需要通过化疗缩小病灶,为手术或放疗创造机会[1-2]。多西他赛是近年来新开发的紫杉醇类药物,具有抗肿瘤活性高、不良反应轻的特点,有明显的抗肿瘤侵袭及转移作用[3]。顺铂是实体瘤治疗的常用药物,本研究对晚期头颈部肿瘤患者给予多西他赛联合顺铂治疗,取得了较好的近期疗效,现报道如下。
1 资料与方法
1.1一般资料
将2013年12月~2015年12月我院收治的58例晚期头颈部肿瘤患者作为研究对象,均经病理组织学确诊,依据不同的治疗方案分为观察组30例和对照组28例,观察组采用多西他赛联合顺铂化疗方案,对照组采用氟尿嘧啶联合顺铂治疗。其中男31例,女27例;年龄42~73岁,平均(59.6±14.9)岁;鼻咽癌21例,喉癌16例,颈部转移癌8例,上颌窦癌5例,口腔癌4例,舌癌2例,甲状腺癌2例;……